These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 34137046)

  • 21. A novel KEL c.1414-1G>T allele in a polish patient with anti-Ku antibody.
    Pelc-Kłopotowska M; Płoski R; Szczałuba K; Szymańska K; Rydzanicz M; Purchla-Szepioła S; Kolasińska K; Lewicka M; Thornton N; Crew VK; Orzińska A; Guz K
    Transfusion; 2022 Sep; 62(9):E43-E44. PubMed ID: 35932201
    [No Abstract]   [Full Text] [Related]  

  • 22. Blood group phenotype distribution in Saudi Arabs.
    Abdelaal MA; Anyaegbu CC; al Sobhi EM; al Baz NM; Hodan K
    Afr J Med Med Sci; 1999; 28(3-4):133-5. PubMed ID: 11205816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three new alleles encoding an apparent Kell
    Puente F; Cemborain-Garcia A; Rodriguez-Wilhelmi P; Garcia-Sanchez F; Rodriguez MA; Lucea I; Ochoa-Garay G
    Transfusion; 2017 Jan; 57(1):221-222. PubMed ID: 27861976
    [No Abstract]   [Full Text] [Related]  

  • 24. Three uncommon KEL alleles in one family with unusual Kell phenotypes explain a 35-year old conundrum.
    Karamatic Crew V; Poole J; Burton N; Daniels G
    Vox Sang; 2014 Apr; 106(3):242-7. PubMed ID: 24795954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Poly(I:C) causes failure of immunoprophylaxis to red blood cells expressing the KEL glycoprotein in mice.
    Escamilla-Rivera V; Liu J; Gibb DR; Santhanakrishnan M; Liu D; Forsmo JE; Eisenbarth SC; Foxman EF; Stowell SR; Luckey CJ; Zimring JC; Hudson KE; Hendrickson JE
    Blood; 2020 May; 135(22):1983-1993. PubMed ID: 32266378
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a novel Kmod -1 allele encoded by 977C>T (Pro326Leu).
    Polin H; Gaszner W; Suessner S; Danzer M; Gabriel C
    Transfusion; 2014 Aug; 54(8):2130-1. PubMed ID: 24588083
    [No Abstract]   [Full Text] [Related]  

  • 27. Five novel silenced KEL*02 alleles.
    Floch A; Velliquette RW; Vege S; Burgos A; Thomas R; Lomas-Francis C; Westhoff CM
    Transfusion; 2021 Nov; 61(11):E77-E79. PubMed ID: 34554576
    [No Abstract]   [Full Text] [Related]  

  • 28. Molecular defects underlying the Kell null phenotype.
    Lee S; Russo DC; Reiner AP; Lee JH; Sy MY; Telen MJ; Judd WJ; Simon P; Rodrigues MJ; Chabert T; Poole J; Jovanovic-Srzentic S; Levene C; Yahalom V; Redman CM
    J Biol Chem; 2001 Jul; 276(29):27281-9. PubMed ID: 11375401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Three missense mutations found in the KEL gene lead to K(mod) or K0 red blood cell phenotypes.
    Matteocci A; Mancuso T; Moscetti A; Collaretti A; Castagna K; Spaccino C; Hutchinson T; Grammatico P; Pierelli L
    Transfusion; 2014 Dec; 54(12):3216-21. PubMed ID: 25041236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The KEL24 and KEL14 alleles of the Kell blood group system.
    Lee S; Naime D; Reid M; Redman C
    Transfusion; 1997 Oct; 37(10):1035-8. PubMed ID: 9354821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Kell blood group system.
    Redman CM; Lee S
    Transfus Clin Biol; 1995; 2(4):243-9. PubMed ID: 8542022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Establishment of KEL*01 and KEL*02 Genotyping to Recruit Uncommon, Kell-positive, Reagent Red Cells Among Thai Blood Donors.
    Intharanut K; Khantisitthiporn O; Kupatawintu P; Leetrakool N; Mitundee S; Nathalang O
    Clin Lab; 2019 Oct; 65(10):. PubMed ID: 31625357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Different KEL gene mRNA transcripts in reticulocyte and non-reticulocyte cells].
    Wang L; Yang Y; Wang C; Zhang J; Guo Z; Li Q; Chen H; Zhu Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Oct; 25(5):520-6. PubMed ID: 18841563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis for the high-incidence antigens of the Kell blood group system.
    Lee S; Naime DS; Reid ME; Redman CM
    Transfusion; 1997; 37(11-12):1117-22. PubMed ID: 9426633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel
    Yearout S; Smith A; Keller J; Keller MA
    Immunohematology; 2022 Jul; 38(2):51-54. PubMed ID: 35852066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Day phenotype: a "new" variant in the Kell blood group system.
    Brown A; Berger R; Lasko D; Brokenshire D; Humphreys J; Stout T; Moore BP; Johnson CL; Mueller KA; Marsh WL
    Rev Fr Transfus Immunohematol; 1982 Dec; 25(6):619-27. PubMed ID: 7170568
    [No Abstract]   [Full Text] [Related]  

  • 37. A KEL gene encoding serine at position 193 of the Kell glycoprotein results in expression of KEL1 antigen.
    Poole J; Warke N; Hustinx H; Taleghani BM; Martin P; Finning K; Crew VK; Green C; Bromilow I; Daniels G
    Transfusion; 2006 Nov; 46(11):1879-85. PubMed ID: 17076841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noninvasive diagnostics of fetal KEL*01.01 allele from maternal plasma of immunized women using digital PCR protocols.
    Orzińska A; Krzemienowska M; Purchla-Szepioła S; Kopeć I; Guz K
    Transfusion; 2022 Apr; 62(4):863-870. PubMed ID: 35191535
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Point mutations in KEL exon 8 determine a high-incidence (RAZ) and a low-incidence (KEL25, VLAN) antigen of the Kell blood group system.
    Lee S; Reid ME; Redman CM
    Vox Sang; 2001 Nov; 81(4):259-63. PubMed ID: 11904003
    [TBL] [Abstract][Full Text] [Related]  

  • 40. KEL*02 alleles with alterations in and around exon 8 in individuals with apparent KEL:1,-2 phenotypes.
    Wester ES; Steffensen R; Ligthart PC; Vad J; de Haas M; Storry JR; Olsson ML
    Vox Sang; 2010 Aug; 99(2):150-7. PubMed ID: 20384970
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.